IL95590A - תכשירים תרופתיים המכילים סאלמטרול ופלוטיקאסון פרופיונאט - Google Patents

תכשירים תרופתיים המכילים סאלמטרול ופלוטיקאסון פרופיונאט

Info

Publication number
IL95590A
IL95590A IL9559090A IL9559090A IL95590A IL 95590 A IL95590 A IL 95590A IL 9559090 A IL9559090 A IL 9559090A IL 9559090 A IL9559090 A IL 9559090A IL 95590 A IL95590 A IL 95590A
Authority
IL
Israel
Prior art keywords
salmeterol
fluticasone propionate
pharmaceutical compositions
inhalation
compositions
Prior art date
Application number
IL9559090A
Other languages
English (en)
Other versions
IL95590A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27264677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL95590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898920392A external-priority patent/GB8920392D0/en
Priority claimed from GB898923644A external-priority patent/GB8923644D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL95590A0 publication Critical patent/IL95590A0/xx
Publication of IL95590A publication Critical patent/IL95590A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL9559090A 1989-09-08 1990-09-05 תכשירים תרופתיים המכילים סאלמטרול ופלוטיקאסון פרופיונאט IL95590A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898920392A GB8920392D0 (en) 1989-09-08 1989-09-08 Medicaments
GB898923644A GB8923644D0 (en) 1989-10-20 1989-10-20 Medicaments
SG166294A SG166294G (en) 1989-09-08 1994-11-18 Inhalation medicaments for treating respiratory disorders

Publications (2)

Publication Number Publication Date
IL95590A0 IL95590A0 (en) 1991-09-16
IL95590A true IL95590A (he) 1996-06-18

Family

ID=27264677

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9559090A IL95590A (he) 1989-09-08 1990-09-05 תכשירים תרופתיים המכילים סאלמטרול ופלוטיקאסון פרופיונאט

Country Status (20)

Country Link
EP (1) EP0416951B1 (he)
JP (1) JP3042867B2 (he)
AT (1) ATE99941T1 (he)
BE (1) BE1003053A3 (he)
CA (1) CA2024916C (he)
CH (1) CH680983C9 (he)
DE (2) DE69005951T2 (he)
DK (1) DK0416951T3 (he)
ES (1) ES2062392T3 (he)
FR (1) FR2651677B1 (he)
HK (1) HK18695A (he)
HU (1) HU211272A9 (he)
IE (1) IE65535B1 (he)
IL (1) IL95590A (he)
IT (1) IT1241996B (he)
LU (1) LU90392I2 (he)
NL (1) NL990012I2 (he)
NZ (1) NZ235221A (he)
PH (1) PH27594A (he)
SG (1) SG166294G (he)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
IL104068A (he) * 1991-12-12 1998-10-30 Glaxo Group Ltd תכשירי רוקחות בתרסיס נטולי חומר פעיל שטח המכילים 1, 1, 1, 2 טטרהפלוארואתאן או 1,1,2,3,3 הפטאפלואור n פרופאן כחומר הודף
SK282826B6 (sk) * 1991-12-18 2002-12-03 Aktiebolaget Astra Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DK1131059T3 (da) 1998-11-13 2003-06-30 Jago Res Ag Tørpulver til inhalation
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
JP2003518484A (ja) * 1999-12-24 2003-06-10 グラクソ グループ リミテッド サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
AR032361A1 (es) * 2000-08-05 2003-11-05 Glaxo Group Ltd Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
US7144908B2 (en) 2001-03-08 2006-12-05 Glaxo Group Limited Agonists of beta-adrenoceptors
DE60224172T2 (de) 2001-03-22 2008-12-04 Glaxo Group Ltd., Greenford Formanilid-derivative als beta2-adrenorezeptor-agonisten
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
JP4446661B2 (ja) 2001-04-30 2010-04-07 グラクソ グループ リミテッド 抗炎症性の、１７α位に環状エステル基を有するアンドロスタンの１７β−カルボチオ酸エステル誘導体
NZ531651A (en) 2001-09-14 2006-02-24 Glaxo Group Ltd Phenethanolamine derivatives for treatment of respiratory diseases
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
EP1757281A3 (en) * 2002-02-04 2009-07-15 Glaxo Group Limited Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
EP1471895B2 (en) † 2002-02-04 2012-03-14 Glaxo Group Limited Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
JP2005519110A (ja) * 2002-03-04 2005-06-30 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規なケイ皮酸塩、その調製方法及び医薬品としての使用
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
JP4755495B2 (ja) 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
CA2534934A1 (en) 2003-08-06 2005-02-17 Galephar M/F Advantageous combinations for inhalation of nacystelyn and bronchodilators
KR20060135873A (ko) * 2004-03-12 2006-12-29 씨아이피엘에이 엘티디. 살메테롤 흡입 제제
CN1997418B (zh) 2004-07-16 2010-08-11 奥米罗有限公司 用于粉状药物给药的吸入器，以及用于与该吸入器一起使用的药粉筒系统
DK2063940T3 (da) 2006-12-22 2012-05-07 Almirall Sa Inhalationsapparat til lægemidler i pulverform
CN101744792B (zh) * 2008-12-17 2013-04-17 张凯 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN107412212B (zh) 2009-05-29 2021-01-22 珍珠治疗公司 经肺递送长效毒蕈碱拮抗剂及长效β2肾上腺素能受体激动剂的组合物及相关方法与系统
CA2905542C (en) 2013-03-15 2022-05-03 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
BR112015027017A2 (pt) * 2013-04-29 2017-07-25 Sanofi Sa composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
FR2588474B1 (fr) * 1985-10-16 1987-11-27 Cird Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste

Also Published As

Publication number Publication date
DE69005951T2 (de) 1994-05-26
CA2024916A1 (en) 1991-03-09
PH27594A (en) 1993-08-31
JPH03167120A (ja) 1991-07-19
IT9048260A0 (it) 1990-09-07
EP0416951B1 (en) 1994-01-12
IE903256A1 (en) 1991-03-13
BE1003053A3 (fr) 1991-11-05
FR2651677A1 (fr) 1991-03-15
SG166294G (en) 1995-06-16
DK0416951T3 (da) 1994-02-14
LU90392I2 (fr) 1999-06-28
JP3042867B2 (ja) 2000-05-22
NZ235221A (en) 1992-11-25
DE69005951D1 (de) 1994-02-24
HU211272A9 (en) 1995-11-28
DE19975040I2 (de) 2006-07-13
NL990012I1 (nl) 1999-07-01
IT1241996B (it) 1994-02-02
NL990012I2 (nl) 1999-09-01
FR2651677B1 (fr) 1993-08-06
ATE99941T1 (de) 1994-01-15
IL95590A0 (en) 1991-09-16
IE65535B1 (en) 1995-11-01
CH680983C1 (he) 2008-06-25
CH680983C9 (he) 2008-08-15
ES2062392T3 (es) 1994-12-16
IT9048260A1 (it) 1992-03-07
EP0416951A1 (en) 1991-03-13
CH680983A5 (he) 1992-12-31
HK18695A (en) 1995-02-17
CA2024916C (en) 2002-07-09

Similar Documents

Publication Publication Date Title
US5270305A (en) Medicaments
EP0416951B1 (en) Medicaments comprising salmeterol and fluticason
US5208226A (en) Medicaments
EP0416950B1 (en) Medicaments
AU673660C (en) New combination of formoterol and budesonide
RU2162689C2 (ru) Пролипосомные порошки для ингаляции
US6369115B1 (en) Stabilized powder formulations
WO2000053187A1 (en) New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
GB2235627A (en) Inhalation medicaments
KR20010014163A (ko) 토코페롤로 안정화된 흡입용 프로리포좀 분말
WO2002028368A1 (en) New combination for the treatment of asthma
EP0613371B1 (en) New combination of formoterol and budesonide
KR100294834B1 (ko) 호흡기질환치료용제약조성물

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXTP Application for extension order is pending
NP Permission for amending the patent specification granted (section 66, patents law 1967)
KB Patent renewed
KB Patent renewed
EXP Patent expired